Atlas Trials

This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure

Clinical trial NCT01035255 · TERMINATED

Trial details

NCT number
NCT01035255
Sponsor
Novartis Pharmaceuticals
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Heart Failure With Reduced Ejection Fraction
Start date
2009-12-01
Primary completion
2014-05-01
Enrollment
8442

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.